Ibritumomab (Anti-CD20)Ibritumomab (Anti-CD20)
Move your mouse over image or click to enlarge

Ibritumomab (Anti-CD20)

Ibritumomab (anti-CD20) is a monoclonal antibody targeting anti-CD20 used to treat B-cell non-Hodgkin's lymphoma. MW: 144.52 KD.
Cat# Size Price Qty Buy
A2896-1mg*25 1mg*25
£4,152.00
A2896-1mg*5 1mg*5
£1,384.00
A2896-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2896

Related Documents